Serum Procalcitonin Levels Are Elevated in Esophageal Cancer Patients with Postoperative Infectious Complications

2005 ◽  
Vol 37 (1) ◽  
pp. 22-28 ◽  
Author(s):  
S. Ito ◽  
N. Sato ◽  
M. Kojika ◽  
Y. Yaegashi ◽  
Y. Suzuki ◽  
...  
2021 ◽  
Author(s):  
Xu Tian ◽  
Yan-Fei Jin ◽  
Zhao-Li Zhang ◽  
Hui Chen ◽  
Wei-Qing Chen ◽  
...  

Abstract Background: Enteral immunonutrition (EIN) has been extensively applied in cancer patients, however its role in esophageal cancer (EC) patients receiving esophagectomy remains unclear. We performed this network meta-analysis to investigate the impact of EIN on patients undergoing surgery for EC and further determine the optimal time of applying EIN.Methods: We searched PubMed, EMBASE, Cochrane library, and China National Knowledgement Infrastructure (CNKI) to identify eligible studies. Categorical data was expressed as the odds ratio with 95% confidence interval (CI), and continuous data was expressed as mean difference (MD) with 95% CI. Pair-wise and network meta-analysis was performed to evaluate the impact of EIN on clinical outcomes using RevMan 5.3 and ADDIS V.1.16.8 softwares. The surface under the cumulative ranking curve (SUCRA) was calculated to rank all nutritional regimes.Results: Total 14 studies involving 1071 patients were included. Pair-wise meta-analysis indicated no difference between EIN regardless of the application time and standard EN (SEN), however subgroup analyses found that postoperative EIN was associated with decreased incidence of total infectious complications (OR=0.47; 95%CI=0.26 to 0.84; p=0.01) and pneumonia (OR=0.47; 95%CI=0.25 to 0.90; p=0.02) and shortened LOH (MD=-1.01; 95%CI=-1.44 to -0.57; p<0.001) compared to SEN, which were all supported by network meta-analyses. Ranking probability analysis further indicated that postoperative EIN has the highest probability of being the optimal option in terms of these three outcomes.Conclusions: Postoperative EIN should be preferentially utilized in EC patients undergoing esophagectomy because it has optimal potential of decreasing the risk of total infectious complications and pneumonia and shortening LOH.OSF registration number: 10.17605/OSF.IO/KJ9UY.


2016 ◽  
Vol 23 (6) ◽  
pp. 2106-2114 ◽  
Author(s):  
Kotaro Yamashita ◽  
Tomoki Makino ◽  
Hiroshi Miyata ◽  
Yasuhiro Miyazaki ◽  
Tsuyoshi Takahashi ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Masaaki Motoori ◽  
Koji Tanaka ◽  
Keijiro Sugimura ◽  
Hiroshi Miyata ◽  
Takuro Saito ◽  
...  

2019 ◽  
Vol 18 (4) ◽  
pp. 43-49
Author(s):  
V. V. Aginova ◽  
N. V. Dmitrieva ◽  
I. N. Petukhova ◽  
Z. V. Grigorievskaya ◽  
N. S. Bagirova ◽  
...  

The purpose of the study was to analyze infectious complications caused by multi-drug-resistant organisms depending on anticancer therapy.Material and Methods. A total of 229 cancer patients with infectious complications of cancer therapy were included into the study.Results. Lung cancer was the most predominant cancer (26.6 %) followed by gastric cancer (25.3 %) and esophageal cancer (14.4 %). Infectious complications occurring after surgery were observed in 83.4 % of the patients. Infectious complications caused by Acinetobacter baumannii were the most common (40.6 %), followed by Klebsiella pneumoniae (28.5 %), Pseudomonas aeruginosa (19.5 %), Staphylococcus spp. (9.4 %), and Enterococcus spp. (1.8 %).Conclusion. Infectious complications occurred more frequently in postoperative cancer patients (p<0.02), and the ESKAPE group pathogens were the leading cause of these infections. 


2001 ◽  
Vol 52 (2) ◽  
pp. 75-81
Author(s):  
Hideo Shimada ◽  
Osamu Chino ◽  
Takayuki Nishi ◽  
Hikaru Tanaka ◽  
Yoshifumi Kise ◽  
...  

2016 ◽  
Vol 27 ◽  
pp. ix78
Author(s):  
A.U. Rehman ◽  
M.A. Iqbal ◽  
S. Saikia ◽  
P.K. Mishra ◽  
S.S. Saluja ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document